Market cap
₹21 Cr
Revenue (TTM)
₹9 Cr
P/E Ratio
--
P/B Ratio
--
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 27.71 | 15.15 | -- |
| EBIT | -- | -- | -278.30 | -209.85 | -- |
| Net Profit | -- | -- | -319.99 | -222.19 | -- |
| EPS | -- | -- | -319.99 | -200.17 | -- |
| Book Value | -- | -- | -7.00 | 49.01 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 3.21 | -- | -8.21 | 5.88 | 11.95 |
| Net Margin
| 1.55 | -- | -7.40 | 4.37 | 7.70 |
| Return on equity
| 6.15 | -- | -7.71 | 4.90 | 21.27 |
| Return on Capital
| 8.43 | -- | -2.79 | 6.73 | 21.35 |
| Return on Assets
| 3.27 | -- | -4.69 | 3.35 | 11.15 |
| Debt to Equity (x)
| -- | -- | 0.78 | 0.34 | 0.31 |
Profitability
ROCE
-2.79
Lower than Peers by 17.11
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-2.79
|
6.73
|
21.35
|
17.38
|
9.66
|
|
Peer Median
|
14.32
|
12.19
|
11.06
|
9.85
|
--
|
ROE
-7.71
Lower than Peers by 18.95
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-7.71
|
4.90
|
21.27
|
30.31
|
12.08
|
|
Peer Median
|
11.24
|
9.26
|
7.17
|
7.54
|
--
|
ROA
-4.69
Lower than Peers by 10.69
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-4.69
|
3.35
|
11.15
|
9.53
|
3.37
|
|
Peer Median
|
6.00
|
7.65
|
3.78
|
3.99
|
--
|
EBIT Margin
-8.21
Lower than Peers by 29.58
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-8.21
|
5.88
|
11.95
|
9.46
|
5.43
|
|
Peer Median
|
21.37
|
--
|
12.49
|
13.66
|
--
|
Net Margin
-7.40
Lower than Peers by 13.54
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-7.40
|
4.37
|
7.70
|
6.43
|
2.27
|
|
Peer Median
|
6.14
|
5.63
|
2.96
|
2.70
|
--
|
Cash Profit Margin
1.85
Higher than Peers by 1.85
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
1.85
|
10.12
|
13.96
|
12.51
|
8.36
|
|
Peer Median
|
0.00
|
--
|
0.00
|
0.00
|
--
|
Revenue Growth
27.71
Lower than Peers by 25.14
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
27.71
|
2.99
|
16.08
|
4.45
|
--
|
|
Peer Median
|
52.85
|
--
|
39.85
|
38.90
|
--
|
EBIT Growth
-278.30
Lower than Peers by 491.87
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-278.30
|
-49.30
|
46.63
|
81.81
|
--
|
|
Peer Median
|
213.56
|
--
|
20.42
|
176.64
|
--
|
Net Profit Growth
-319.99
Lower than Peers by 530.04
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-319.99
|
-40.53
|
39.44
|
195.47
|
--
|
|
Peer Median
|
210.06
|
--
|
12.85
|
218.06
|
--
|
EPS Growth
-319.99
Lower than Peers by 522.76
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-319.99
|
-57.19
|
6.72
|
195.47
|
--
|
|
Peer Median
|
202.77
|
--
|
33.33
|
200.00
|
--
|
Book Value Growth
-7.00
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-7.00
|
163.14
|
145.37
|
35.53
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.78
Higher than Peers by 0.54
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.78
|
0.34
|
0.31
|
1.27
|
2.03
|
|
Peer Median
|
0.24
|
0.22
|
0.20
|
0.19
|
--
|
Short term debt to equity ratio
0.08
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.08
|
0.06
|
0.18
|
0.65
|
0.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.46
Lower than Peers by 0.57
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
1.46
|
2.30
|
1.74
|
0.59
|
0.74
|
|
Peer Median
|
2.03
|
1.99
|
2.03
|
1.95
|
--
|
Quick Ratio
0.69
Lower than Peers by 4.74
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.69
|
1.03
|
0.86
|
0.42
|
0.42
|
|
Peer Median
|
5.42
|
--
|
1.12
|
1.24
|
--
|
Interest Coverage
-1.46
Lower than Peers by 5.41
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-1.46
|
3.89
|
5.34
|
3.01
|
1.55
|
|
Peer Median
|
3.95
|
4.14
|
2.98
|
3.48
|
--
|
Operating Efficiency
Debtors to sales
14.16
Lower than Peers by 36.04
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
14.16
|
17.88
|
15.28
|
13.62
|
12.93
|
|
Peer Median
|
50.20
|
--
|
29.85
|
41.06
|
--
|
Asset Turnover
0.61
Lower than Peers by 2.32
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.61
|
0.75
|
1.44
|
1.48
|
1.48
|
|
Peer Median
|
2.93
|
--
|
1.55
|
3.06
|
--
|
Receivable days
51.38
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
51.38
|
59.70
|
49.29
|
47.45
|
47.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
103.35
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
103.35
|
98.74
|
44.96
|
30.62
|
38.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
57.11
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
57.11
|
83.68
|
84.03
|
90.36
|
63.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
97.62
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
97.62
|
74.76
|
10.22
|
-12.29
|
22.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
--
|
31.28
|
--
|
--
|
--
|
|
Peer Median
|
36.58
|
44.20
|
39.23
|
34.42
|
--
|
Price / Book Value
1.76
Lower than Peers by 0.55
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
1.76
|
2.12
|
--
|
--
|
--
|
|
Peer Median
|
2.31
|
2.96
|
2.56
|
2.03
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
46.68
Higher than Peers by 32.75
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
46.68
|
23.35
|
2.45
|
3.65
|
5.64
|
|
Peer Median
|
13.94
|
23.15
|
24.73
|
22.79
|
--
|
Market Cap
14
Lower than Peers by 40
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
14
|
19
|
--
|
--
|
--
|
|
Peer Median
|
55
|
55
|
58
|
40
|
--
|